# Risks of buying Whoop stock

Private Whoop shares are hard to sell, can be blocked from transfer, and come with far less information than a listed stock. Whoop's valuation has nearly tripled since 2021, its health features have drawn FDA scrutiny, and it competes with Apple, Google and Garmin. An investor can lose the full amount.

[Buy Whoop stock on Clarity.com](https://www.clarity.com/browse-companies/whoop-stock?utm_source=supercluster&utm_medium=affiliate&utm_campaign=buywhoopstock.com)

Last checked: November 20, 2026. Canonical: https://buywhoopstock.com/risks/

## Can you sell Whoop shares whenever you like?

No. Whoop shares have no exchange, so a resale needs a willing private buyer, and Whoop's [transfer restrictions](https://buywhoopstock.com/whoop-stock-glossary/#transfer-restrictions) apply again when you sell. Clarity's disclosures warn that private securities are generally illiquid, that investors may not be able to sell when they want or at all, and that holders should be prepared to keep them for an indefinite period.

Sources: [Clarity: Disclosures](https://www.clarity.com/disclosures), [Clarity: Whoop stock](https://www.clarity.com/browse-companies/whoop-stock)

## Can Whoop stop you from buying its shares?

Yes. A Whoop purchase completes only if it clears the company's [right of first refusal](https://buywhoopstock.com/whoop-stock-glossary/#right-of-first-refusal) and any transfer restrictions or approvals. Whoop can decline the transfer, or use a right of first refusal to buy the shares itself on the agreed terms. Clarity says that agreeing a price on its platform does not guarantee the transfer will be approved or completed.

Sources: [Clarity: Whoop stock](https://www.clarity.com/browse-companies/whoop-stock), [Clarity: Investing in pre-IPO companies](https://www.clarity.com/guides/investing-in-pre-ipo-companies), [Clarity: Disclosures](https://www.clarity.com/disclosures)

## How much financial information does Whoop publish?

Whoop publishes far less than a listed company. Its headline numbers, such as a $1.1 billion bookings run rate at the end of 2025, come from company announcements rather than public filings. Clarity warns that information on private companies may be incomplete, outdated or inaccurate, and that sellers, often employees or early investors, may know more about Whoop than the buyer does.

Sources: [Mubadala, March 2026](https://www.mubadala.com/en/news/whoop-raises-dollar-575-million-at-dollar-10-billion-valuation-to-advance-global-health-platform), [Clarity: Disclosures](https://www.clarity.com/disclosures), [Clarity: Investing in pre-IPO companies](https://www.clarity.com/guides/investing-in-pre-ipo-companies), [Investor.gov (SEC)](https://www.investor.gov/introduction-investing/general-resources/news-alerts/alerts-bulletins/investor-bulletins/private-placements-under-regulation-d-updated-investor-bulletin)

## Could Whoop's valuation fall?

Yes. Whoop's valuation rose from $3.6 billion in August 2021 to $10.1 billion in March 2026, and private valuations can fall as well as rise. Clarity notes that private trade prices can differ widely from one deal to the next and may not reflect fair value, and that future funding rounds can dilute the stakes of existing Whoop holders.

- One private company is not a diversified investment.
- Private company stock is speculative, and the entire investment can be lost.

Related: [What is Whoop's stock price?](https://buywhoopstock.com/whoop-stock-price/#what-is-whoop-stock-price)

Sources: [TechCrunch, March 2026](https://techcrunch.com/2026/03/31/whoop-valuation-10b-series-g-fundraise/), [Clarity: Disclosures](https://www.clarity.com/disclosures)

## Has Whoop had problems with the FDA?

Yes. In July 2025 the FDA sent Whoop a warning letter saying its Blood Pressure Insights feature was being marketed without clearance or approval. Whoop changed the feature and its labeling, and in June 2026 the FDA said it would not enforce device rules against the modified version. The FDA's closeout covers only that modified feature, not other Whoop products.

- The WHOOP MG band, launched in May 2025, includes an FDA-cleared electrocardiogram.
- Whoop now offers Quest blood testing reviewed by clinicians and on-demand video visits with clinicians in its app, which take it further into healthcare.

Sources: [FDA warning letter, July 2025](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/whoop-inc-709755-07142025), [FDA closeout letter, June 2026](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/whoop-inc-709755-06172026), [The Next Web, April 2026](https://thenextweb.com/news/whoop-series-g-575m-valuation-ipo-health-platform), [Fierce Healthcare, November 2026](https://www.fiercehealthcare.com/health-tech/hlth-2026-how-whoop-aims-play-bigger-role-healthcare)

## Which listed companies compete with Whoop?

Whoop's listed rivals include Apple, Garmin and Alphabet, whose Google unit released a $100 screenless Fitbit Air wearable in May 2026. Their shares trade on public exchanges and can be bought in any brokerage account, but none gives ownership of Whoop. Oura, the smart ring maker, remains private after postponing its Nasdaq listing in September 2026.

- Whoop gives away the hardware and sells memberships that start at $200 a year; the Fitbit Air has an optional $10 monthly plan.
- The Next Web noted in April 2026 that Whoop's $10.1 billion valuation was roughly a quarter of Garmin's market value of about $40 billion.

Related: [When is the Whoop IPO?](https://buywhoopstock.com/whoop-ipo/#when-is-the-whoop-ipo)

Sources: [The Next Web, April 2026](https://thenextweb.com/news/whoop-series-g-575m-valuation-ipo-health-platform), [Athletech News, August 2026](https://athletechnews.com/whoop-plans-to-double-size-of-boston-headquarters-ahead-of-ipo/), [Irish Times (Financial Times), September 2026](https://www.irishtimes.com/business/markets/2026/09/29/smart-ring-start-up-oura-delays-ipo-amid-market-uncertainty/)

---
Buy Whoop Stock is an independent information site. It is not affiliated with, endorsed by or sponsored by WHOOP, Inc.. Links to Clarity are affiliate links: the site may be paid when a reader opens an account. Nothing here is investment advice. Shares in private companies are illiquid, carry a high risk of loss, and are generally open only to accredited investors.
